Article
Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
Molecular & cellular proteomics : MCP - 1 Jan 2017
Doll Sophia, Urisman Anatoly, Oses-Prieto Juan A, Arnott David, Burlingame Alma L
Abstract excerpt
Glioblastoma multiformes (GBMs) are high-grade astrocytomas and the most common brain malignancies. Primary GBMs are often associated with disturbed RAS signaling, and expression of oncogenic HRAS results in a malignant phenotype in glioma cell lines. Secondary GBMs arise from lower-grade astrocytomas, have slower progression than primary tumors, and contain IDH1 mutations in over 70% of cases. Despite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
